Laddar...
An update on PARP inhibitors for the treatment of cancer
The development of poly (adenosine diphosphate [ADP]) ribose polymerase (PARP) inhibitors (PARPi) has progressed greatly over the last few years and has shown encouraging results in the BRCA1/2 mutation–related cancers. This article attempts to summarize the rationale and theory behind PARPi, the cl...
Sparad:
| I publikationen: | Onco Targets Ther |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4348139/ https://ncbi.nlm.nih.gov/pubmed/25750544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S30793 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|